Adult treatment panel guidelines (ATP III) for hypercholestrolemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(/* Adult Treatment Panel guidelines (ATP III) for serum triglyceride {{cite journal| author=Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults| title=Executive Summary of The Third Report of The National Choleste) |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
The Adult Treatment Panel (ATP III) has adopted a classification for serum [[triglyceride]] level that helps in making treatment decisions. Elevated triglycerides are an independent risk factor for [[coronary heart diseases]]. It is commonly observed in persons with the [[metabolic syndrome]], [[obesity]], [[physical inactivity]], [[smoking]], excess [[alcohol]] intake, high-[[carbohydrate]] diets , [[diabetes type 2]], [[chronic renal failure]], [[nephrotic syndrome]], certain drugs like [[corticosteroid]]s, [[estrogen]]s, [[retinoid]]s and [[genetic]] disorders (familial combined hyperlipidemia, [[familial hypertriglyceridemia]], and [[familial dysbetalipoproteinemia]]). | The Adult Treatment Panel (ATP III) has adopted a classification for serum [[triglyceride]] level that helps in making treatment decisions. Elevated triglycerides are an independent risk factor for [[coronary heart diseases]]. It is commonly observed in persons with the [[metabolic syndrome]], [[obesity]], [[physical inactivity]], [[smoking]], excess [[alcohol]] intake, high-[[carbohydrate]] diets , [[diabetes type 2]], [[chronic renal failure]], [[nephrotic syndrome]], certain drugs like [[corticosteroid]]s, [[estrogen]]s, [[retinoid]]s and [[genetic]] disorders (familial combined hyperlipidemia, [[familial hypertriglyceridemia]], and [[familial dysbetalipoproteinemia]]). | ||
==Adult Treatment Panel guidelines (ATP III) for LDL Cholesterol and Non-HDL Cholesterol <ref name="pmid11368702">{{cite journal| author=Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults| title=Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). | journal=JAMA | year= 2001 | volume= 285 | issue= 19 | pages= 2486-97 | pmid=11368702 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11368702 }} </ref> == | |||
<table> | |||
{|class="wikitable" border="1" style="text-align:center; width:750px;" | |||
|-style="background:#CDC9C9" | |||
| Risk category | |||
| LDL goal, mg/dL | |||
|Non-HDL goal, mg/dL | |||
|- | |||
| CHD and CHD risk equivalent (10 year risk for CHD is >20%) | |||
| < 100 | |||
| < 130 | |||
|- | |||
| Multiple (2+) risk factor (10 year risk for CHD is <20%) | |||
| < 130 | |||
| < 160 | |||
|- | |||
| 0-1 risk factors | |||
| < 160 | |||
| < 190 | |||
|- | |||
|} | |||
==Adult Treatment Panel guidelines (ATP III) for serum triglyceride <ref name="pmid11368702">{{cite journal| author=Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults| title=Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). | journal=JAMA | year= 2001 | volume= 285 | issue= 19 | pages= 2486-97 | pmid=11368702 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11368702 }} </ref> == | ==Adult Treatment Panel guidelines (ATP III) for serum triglyceride <ref name="pmid11368702">{{cite journal| author=Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults| title=Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). | journal=JAMA | year= 2001 | volume= 285 | issue= 19 | pages= 2486-97 | pmid=11368702 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11368702 }} </ref> == | ||
Revision as of 20:03, 26 September 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]
Overview
The Adult Treatment Panel (ATP III) has adopted a classification for serum triglyceride level that helps in making treatment decisions. Elevated triglycerides are an independent risk factor for coronary heart diseases. It is commonly observed in persons with the metabolic syndrome, obesity, physical inactivity, smoking, excess alcohol intake, high-carbohydrate diets , diabetes type 2, chronic renal failure, nephrotic syndrome, certain drugs like corticosteroids, estrogens, retinoids and genetic disorders (familial combined hyperlipidemia, familial hypertriglyceridemia, and familial dysbetalipoproteinemia).
Adult Treatment Panel guidelines (ATP III) for LDL Cholesterol and Non-HDL Cholesterol [1]
| Risk category | LDL goal, mg/dL | Non-HDL goal, mg/dL |
| CHD and CHD risk equivalent (10 year risk for CHD is >20%) | < 100 | < 130 |
| Multiple (2+) risk factor (10 year risk for CHD is <20%) | < 130 | < 160 |
| 0-1 risk factors | < 160 | < 190 |
Adult Treatment Panel guidelines (ATP III) for serum triglyceride [1]
| Classification | TG level, mg/dL |
| Normal TG level | < 150 |
| Borderline-high TG level | 150-199 |
| High TG level | 200-499 |
| Very high TG level | >500 |
References
- ↑ 1.0 1.1 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001). "Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)". JAMA. 285 (19): 2486–97. PMID 11368702.